Macular edema after cataract surgery in eyes with and without pseudoexfoliation syndrome

Show full item record



Permalink

http://hdl.handle.net/10138/320955

Citation

Ilveskoski , L , Taipale , C , Holmstrom , E J & Tuuminen , R 2019 , ' Macular edema after cataract surgery in eyes with and without pseudoexfoliation syndrome ' , European Journal of Ophthalmology , vol. 29 , no. 5 , pp. 504-509 . https://doi.org/10.1177/1120672118799622

Title: Macular edema after cataract surgery in eyes with and without pseudoexfoliation syndrome
Author: Ilveskoski, Lotta; Taipale, Claudia; Holmstrom, Emil J.; Tuuminen, Raimo
Contributor: University of Helsinki, Department of Ophthalmology and Otorhinolaryngology
University of Helsinki, Silmäklinikka
University of Helsinki, University of Helsinki
University of Helsinki, Medicum
Date: 2019-09
Language: eng
Number of pages: 6
Belongs to series: European Journal of Ophthalmology
ISSN: 1120-6721
URI: http://hdl.handle.net/10138/320955
Abstract: Background: The purpose of the study was to identify macular edema after cataract surgery in eyes with and without pseudoexfoliation syndrome. The study was a post-hoc analysis of a randomized, double-blind, prospective single-center study. Patients were enrolled between January 2016 and October 2016 as per the national guidelines for the management of cataract in the Department of Ophthalmology, Kymenlaakso Central Hospital, Kotka, Finland. Methods: One hundred and fifty-six eyes of 149 patients undergoing routine cataract surgery. Postoperatively anti-inflammatory medication was either dexamethasone (N = 78) or diclofenac (N = 78). Spectral domain optical coherence tomography imaging and laser flare meter measurement of the anterior chamber were conducted before surgery and at the control visit 28 days postoperatively. Results: Baseline variables were comparable between eyes with pseudoexfoliation syndrome (N = 32) and those without (N = 124), except for intraocular pressure (P = 0.002) and glaucoma medication (P <0.001). In patients having pseudoexfoliation syndrome, central retinal thickness increase (mean +/- standard error of the mean) was 63.3 +/- 35.5 mu m for dexamethasone and 17.6 +/- 5.8 mu m for diclofenac, compared to 28.9 +/- 8.0 mu m (P = NS) and 6.9 +/- 1.3 mu m (P = 0.014) in eyes without pseudoexfoliation syndrome, respectively. Aqueous flare at 28 days was 25.8 +/- 5.4 pu/ms for patients with pseudoexfoliation syndrome and 18.3 +/- 1.8 pu/ms for those without (P = 0.030). Best corrected visual acuity gain and best corrected visual acuity at 28 days were less in patients having pseudoexfoliation syndrome compared to those without (0.39 +/- 0.07 vs 0.59 +/- 0.03 decimals, P = 0.007; and 0.77 +/- 0.06 vs 0.92 +/- 0.03 decimals, P = 0.008, respectively). Conclusion: Eyes with pseudoexfoliation syndrome may be predisposed to an increased aqueous flare and macular edema after cataract surgery. This study outlines the need to determine the optimal anti-inflammatory medication after cataract surgery in patients with pseudoexfoliation syndrome.
Subject: Aqueous flare
cataract
central retinal thickness
macular edema
phacoemulsification
pseudoexfoliation syndrome
FUNDUS FLUORESCEIN ANGIOGRAPHY
OPTICAL COHERENCE TOMOGRAPHY
EXFOLIATION SYNDROME
PHACOEMULSIFICATION
IMPLANTATION
GLAUCOMA
3125 Otorhinolaryngology, ophthalmology
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
1120672118799622.pdf 226.1Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record